Massive study to track stem cell patients in ICU
NCT ID NCT07328724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 4,000 people who had a stem cell transplant and later became critically ill, requiring intensive care. Researchers will collect information on their health, treatments, and survival. The goal is to learn more about what happens to these patients and how to improve their care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Affiliated Hospital of Harbin Medical University
Harbin, China
-
First Affiliated Hospital of Zhejiang University
Hangzhou, China
-
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, China
-
Peking University People's Hospital
Beijing, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
-
Xinqiao hospital of the third military medical university
Chongqing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- A gentle touch from family may calm the ICU storm
- Can remote exercise rebuild strength in kids after ICU?
- Fasting in the ICU: a metabolic key to immune response?